Effects of Treatment on Angiogenic (Vascular Endothelial Growth Factor-2 and Matrix Metalloproteinase-2) and Antiangiogenic (Endostatin and Thrombospondin-1) Factors in Non-muscle Invasive Bladder Carcinoma
Journal Title: JOURNAL OF UROLOGICAL SURGERY - Year 2017, Vol 4, Issue 2
Abstract
Objective: We aimed to investigate possible effects of treatment on angiogenic [vascular endothelial growth factor-2 (VEGF-2) and matrix metalloproteinase-2 (MMP-2)] and antiangiogenic [endostatin (ES) and thrombospondin-1 (TSP-1)] factors in non-muscle invasive bladder carcinoma (NMIBC). Materials and Methods: Thirty NMIBC patients and 30 age-matched controls were included in the study. For the above-mentioned markers, peripheral blood samples were drawn at three time points to be studied by enzyme-linked immunosorbent assay: before transurethral resection of bladder tumor (TURBT), at first control (20 days after the operation) and second control (at the end of intravesical immunotherapy). The mean blood levels obtained in the three measurements and those in patients and controls were compared statistically. Results: The mean levels of VEGF-2 and MMP-2 in patients before TURBT were found to be statistically significantly higher than in controls (p=0.04 and p=0.01, respectively), while no significant differences were obtained between the mean ES and TSP-1 levels (p=0.95 and p=0.99, respectively). It was also found that the VEGF-2 and MMP-2 levels were significantly decreased after TURBT (p=0.03 and p=0.01, respectively), but the tendency of these decrease was not found to be statistically significant between the first and second controls. Conclusion: Elevated VEGF-2 and MMP-2 levels in patients with NMIBC were significantly decreased after and probably due to the TURBT, which leads to a conclusion that these angiogenic markers may be used for follow-up of NMIBC.
Authors and Affiliations
Gökhan Temeltaş, Funda Kosova, Oktay Üçer, Talha Müezzinoğlu, Zeki Arı
Keywords
Related Articles
- EP ID EP243783
- DOI 10.4274/jus.1306
- Views 90
- Downloads 0
Percutaneous Removal of a Broken Malecot Nephrostomy Tube
We report a case of a broken re-entry Malecot nephrostomy tube inserted after an uneventful percutaneous nephrolithotomy (PCNL) procedure. The remained parts within the renal pelvis and around the kidney were removed usi...
Duodenorenal Fistula as a Complication of Radiofrequency Ablation of Hepatic Metastasis of Renal Cell Carcinoma
Duodenorenal fistula is a rare condition. The right kidney and the second part of the duodenum are in close anatomic proximity. Although unusual, fistulae can occur between these two anatomic structures. We report a pati...
Paratesticular Metastasis of High Grade Prostate Cancer Clinically Mimicking Hemato/Pyo-hydrocele
Secondary metastatic lesions of the testicles are very rare and they originate mainly from prostate adenocarcinoma. They are generally diagnosed incidentally, however, they very rarely manifest as a palpable testicular m...
Combined Radiation and Hormonal Therapy for Squamous Cell Carcinoma of the Prostate: A Case Report and Review of the Literature
Squamous cell carcinoma (SCC) of the prostate is a rare entity, with a prevalence of 0.6-1% among all prostatic carcinomas. Prostatic SCC has a poor prognosis. Although there are a number of treatment modalities, none of...
Complete Urethral Rupture Related with Penile Fracture Occurring during Sexual Intercourse: A Case Report and Review of the Literature
Complete disruption of the urethra due to penile fracture is a very rare occurrence. Herein, we report a case of a 39-year-old man who presented with penile fracture and complete disruption of the urethra as a result of...